Articles from BIOTECH Patent News (March 1, 2006)

Title	Author	Type	Words
AIDS group lauds WHO report urging ease of drug patents in poor countries.			737
Argentis to market dry eye treatment patented by Southern College of Optometry.			533
Berlex Schering AG sued for infringement of Loestrin 24 Fe patent.			207
Biosite and Oxford Genome Sciences form colorectal cancer collaboration.			687
Biotech City and Genopole sign agreement that opens scientific and commercial exchange channels.			442
Cadence completes acquisition of IV acetaminophen.			234
Cardium wins patent dispute with Boston Scientific and Arch Development Corporation,.			1781
CEL-SCI files patent application for prevention/treatment of avian flu.			246
CFD Therapeutics formed to advance monoclonal antibodies for cancer.			567
Chromos signs agreement with AppTec to manufacture multiple sclerosis drug.			569
Diversa obtains United States patent.			140
Dynavax to acquire Rhein Biotech from Crucell.			780
EntreMed presents preclinical results for combination therapy with 2ME2 in brain and colon cancer.			698
GlaxoSmithKline and Pharmacopeia Enter Into Drug Discovery and Development Alliance.			632
GlaxoSmithKline and Sirna form major alliance in RNAi-based therapeutics for respiratory disease.			552
HemoCue will enforce decision in patent infringement suit against EKF.			282
Idenix licenses valopicitabine to Novartis.			952
Incorporated Administrative Agency obtains United States patent.			107
Innovex and StoneBrige Pharma form parternship.			560
Judge upholds jury verdicts on Cordis patents infringed by Boston Scientific and Medtronic.			179
Large Scale Biology obtains United States patent.			88
Mannatech enforces its ambrotose patent against nutritional supplements firm.			382
Max-Planck obtains United States patent.		Brief article	119
Millenia's infectious disease program to develop malaria and HIV/AIDS drug discovery targets puts financing in place to ensure project completion.			608
Nabi acquires exclusive rights to Phase III organ transplantation rejection antibody product.			986
Oncolytics announces issuance of 15th United States patent.			167
Oragenics seeks patent for agent to treat obesity.			246
Pharmacopeia licenses hypertension, congestive heart failure and diabetic nephropathy candidates from Bristol-Myers Squibb.			520
SGX Pharmaceuticals forms collaboration to commercialize BCR-ABL inhibitors for the treatment of chronic myelogenous leukemia.			885
Sirna granted first broad siRNA patent for a gene target.			550
Solulink introduces a biotinylation reagent with built-in biotin quantification.			352
Summit's licensing agreement with BioGenesis key to Nigerian environmental cleanup project.			598
ThermoGenesis receives allowance of third patent for autologous thrombin processing device.			413
University of Texas obtains United States patent.		Brief article	169
Wyeth acquires an additional stake in Wyeth K.K. Japan.			215
Wyeth forms translational collaboration with universities in Scotland.			422
Zygogen licenses transgenic zebrafish technology to DanioLabs for internal drug discovery.			627